{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T21:16:01Z","timestamp":1774127761282,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2006,6,9]],"date-time":"2006-06-09T00:00:00Z","timestamp":1149811200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefe's Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2006,11,24]]},"DOI":"10.1007\/s00417-006-0318-2","type":"journal-article","created":{"date-parts":[[2006,6,8]],"date-time":"2006-06-08T08:53:34Z","timestamp":1149756814000},"page":"1591-1600","source":"Crossref","is-referenced-by-count":59,"title":["Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study"],"prefix":"10.1007","volume":"244","author":[{"given":"Maria L.","family":"Ribeiro","sequence":"first","affiliation":[]},{"given":"Andras I.","family":"Seres","sequence":"additional","affiliation":[]},{"given":"Angela M.","family":"Carneiro","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Stur","sequence":"additional","affiliation":[]},{"given":"Alain","family":"Zourdani","sequence":"additional","affiliation":[]},{"given":"Patricia","family":"Caillon","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 G.","family":"Cunha-Vaz","sequence":"additional","affiliation":[]},{"name":"on behalf of the DX-Retinopathy Study Group","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2006,6,9]]},"reference":[{"key":"318_CR1","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1046\/j.1464-5491.2001.00589.x","volume":"18","author":"CC Bailey","year":"2001","unstructured":"Bailey CC, Sparrow JM (2001) Visual symptomatology in patients with sight-threatening diabetic retinopathy. Diabet Med 18:883\u2013888","journal-title":"Diabet Med"},{"key":"318_CR2","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0889-8529(02)00017-8","volume":"31","author":"K Bergerhoff","year":"2002","unstructured":"Bergerhoff K, Clar C, Richter B (2002) Aspirin in diabetic retinopathy. A systematic review. Endocrinol Metab Clin N Am 31:779\u2013793","journal-title":"Endocrinol Metab Clin N Am"},{"key":"318_CR3","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1742-1241.1999.tb11820.x","volume":"53","author":"P Berthet","year":"1999","unstructured":"Berthet P, Farine JC, Barras JP (1999) Calcium dobesilate: pharmacological profile related to its use in diabetic retinopathy. Int J Clin Pract 53:631\u2013636","journal-title":"Int J Clin Pract"},{"key":"318_CR4","first-page":"283","volume":"20","author":"PG Binkhorst","year":"1976","unstructured":"Binkhorst PG, Van Bijsterveld OP (1976) Calcium Dobesilate versus placebo in the treatment of diabetic retinopathy: a double-blind cross-over study. Curr Ther Res Clin Exp 20:283\u2013288","journal-title":"Curr Ther Res Clin Exp"},{"key":"318_CR5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1472-8206.1998.tb00943.x","volume":"12","author":"J Brunet","year":"1998","unstructured":"Brunet J, Farine JC, Garay RP et al (1998) In vitro antioxydant properties of calcium dobesilate. Fundam Clin Pharmacol 12:205\u2013212","journal-title":"Fundam Clin Pharmacol"},{"key":"318_CR6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0014-2999(98)00604-9","volume":"358","author":"J Brunet","year":"1998","unstructured":"Brunet J, Farine JC, Garay RP et al (1998) Angioprotective action of calcium dobesilate against reactive oxygen species-induced capillary permeability in the rat. Eur J Pharmacol 358:213\u2013220","journal-title":"Eur J Pharmacol"},{"key":"318_CR7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ophtha.2003.05.010","volume":"111","author":"H Buch","year":"2004","unstructured":"Buch H, Vinding T, La Cour M et al (2004) Prevalence and causes of visual impairment and blindness among 9980 Scandinavian adults: The Copenhagen City Eye Study. Ophthalmology 111:53\u201361","journal-title":"Ophthalmology"},{"key":"318_CR8","first-page":"703","volume":"25","author":"SE Bursell","year":"1984","unstructured":"Bursell SE, Delori Fac, Yoshida A et al (1984) Vitreous fluorophotometric evaluation of diabetics. Invest Ophthalmol Vis Sci 25:703\u2013710","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"318_CR9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0140-6736(97)06209-0","volume":"351","author":"N Chaturvedi","year":"1998","unstructured":"Chaturvedi N, Sjolie AK, Stephenson JM et al (1998) Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin\u2013Dependent Diabetes Mellitus. Lancet 351:28\u201331","journal-title":"Lancet"},{"key":"318_CR10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3317\/jraas.2002.047","volume":"3","author":"N Chaturvedi","year":"2002","unstructured":"Chaturvedi N, Sjoelie AK, Svensson A (2002) The Diabetic Retinopathy Candesartan Trials (DIRECT) Programme, rationale and study design. J Renin Angiotensin Aldosterone Syst 3:255\u2013261","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"318_CR11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2337\/diab.34.1.53","volume":"34","author":"JG Cunha-Vaz","year":"1985","unstructured":"Cunha-Vaz JG, Gray JR, Zeimer RC, Mota MC, Ishimoto BH, Leite EB (1985) Characterization of the early stages of diabetic retinopathy by vitreous fluorophotometry. Diabetes 34:53\u201359","journal-title":"Diabetes"},{"key":"318_CR12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF00920936","volume":"231","author":"JG Cunha-Vaz","year":"1993","unstructured":"Cunha-Vaz JG, Leite E, Castro Sousa JP, Faria de Abreu JR (1993) Blood-retinal barrier permeability and its relation to progression of diabetic retinopathy. A four year follow-up study. Graefe\u2019s Arch Clin Exp Ophthalmol 231:141\u2013145","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"318_CR13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s004170050075","volume":"236","author":"J Cunha-Vaz","year":"1998","unstructured":"Cunha-Vaz J, Lobo C, Sousa JC et al (1998) Progression of retinopathy and alteration of the blood-retinal barrier in patients with type 2 diabetes: a 7-year prospective follow-up study. Graefe\u2019s Arch Clin Exp Ophthalmol 236:264\u2013268","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"318_CR14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1159\/000027528","volume":"214","author":"JG Cunha-Vaz","year":"2000","unstructured":"Cunha-Vaz JG (2000) Diabetic retinopathy: surrogate outcomes for drug development for diabetic retinopathy. Ophthalmologica 214:377\u2013380","journal-title":"Ophthalmologica"},{"key":"318_CR15","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2337\/diab.38.4.491","volume":"38","author":"DAMAD Study Group","year":"1989","unstructured":"DAMAD Study Group (1989) Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy. A multicenter randomized controlled clinical trial. The DAMAD Study Group. Diabetes 38:491\u2013498","journal-title":"Diabetes"},{"issue":"suppl. 3","key":"318_CR16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2337\/diab.34.3.S42","volume":"34","author":"MD Davis","year":"1985","unstructured":"Davis MD, Hubbard LD, Trautman J, Klein R (1985) Studies of retinopathy. Methodology for assessment and classification with fundus photographs. Diabetes 34 (suppl. 3):42\u201349","journal-title":"Diabetes"},{"issue":"5 Suppl","key":"318_CR17","first-page":"807","volume":"98","author":"ETDRS Research Group","year":"1991","unstructured":"ETDRS Research Group (1991) Classification of diabetic retinopathy from fluorescein angiograms. ETDRS report number 11. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 98 (5 Suppl):807\u2013822","journal-title":"Ophthalmology"},{"key":"318_CR18","first-page":"174","volume":"36","author":"SS Feman","year":"1995","unstructured":"Feman SS, Leonard-Martin TC, Andrews JS, Armbruster CC, Burdge TL, Debelak JD, Lanier A, Fischer AG (1995) A quantative system to evaluate diabetic retinopathy from fundus photographs. IOVS 36:174\u2013181","journal-title":"IOVS"},{"key":"318_CR19","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0002-9394(02)01321-1","volume":"133","author":"RN Frank","year":"2002","unstructured":"Frank RN (2002) Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors. Am J Ophthalmol 133:693\u2013698","journal-title":"Am J Ophthalmol"},{"key":"318_CR20","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1159\/000307064","volume":"168","author":"H Freyler","year":"1974","unstructured":"Freyler H (1974) Microvascular protection with calcium dobesilate (Doxium) in diabetic retinopathy. Ophthalmologica 168:400\u2013416","journal-title":"Ophthalmologica"},{"key":"318_CR21","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1002\/(SICI)1097-0258(19971230)16:24<2855::AID-SIM749>3.0.CO;2-Y","volume":"16","author":"LJ Frison","year":"1997","unstructured":"Frison LJ, Pocock SJ (1997) Linearly divergent treatment effects in clinical trials with repeated measures: efficient analysis using summary statistics. Stat Med 16:2855\u20132872","journal-title":"Stat Med"},{"key":"318_CR22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2165\/00024677-200504040-00003","volume":"4","author":"P Garay","year":"2005","unstructured":"Garay P, Hannaert P, Chiavaroli C (2005) Calcium dobesilate in the treatment of diabetic retinopathy. Treat Endocrinol 4:221\u2013232","journal-title":"Treat Endocrinol"},{"key":"318_CR23","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1464-5491.2003.00979.x","volume":"20","author":"RE Gilbert","year":"2003","unstructured":"Gilbert RE, Krum H, Wilkinson-Berka J, Kelly DJ (2003) The renin-angiotensin system and the long-term complications of diabetes: pathophysiological and therapeutic considerations. Diabet Med 20:607\u2013621","journal-title":"Diabet Med"},{"key":"318_CR24","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0306-9877(02)00316-X","volume":"59","author":"C Giusti","year":"2002","unstructured":"Giusti C (2002) Is medical treatment for diabetic retinopathy still an unreal dream? Med Hypoth 59:706\u2013709","journal-title":"Med Hypoth"},{"key":"318_CR25","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0002-9610(85)90443-X","volume":"150","author":"P Gloviczki","year":"1985","unstructured":"Gloviczki P, Fowl RJ, Hollier LH et al (1985) Prevention of platelet deposition by ibuprofen and calcium dobesilate in expanded polytetrafluoroethylene vascular grafts. Am J Surg 150:589\u2013592","journal-title":"Am J Surg"},{"key":"318_CR26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2008-1035343","volume":"206","author":"A Haas","year":"1995","unstructured":"Haas A (1995) Einfluss von Kalziumdobesilat auf die Progression der diabetischen Retinopathie. Klin Monatsbl Augenheilkd 206:17\u201321","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"318_CR27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1444-0938.1999.tb06759.x","volume":"82","author":"CA Harper","year":"1999","unstructured":"Harper CA (1999) Treatment of diabetic retinopathy. Clin Exp Optom 82:98\u2013101","journal-title":"Clin Exp Optom"},{"key":"318_CR28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0161-6420(84)34336-6","volume":"91","author":"BEK Klein","year":"1984","unstructured":"Klein BEK, Davis MD, Segal P et al (1984) Diabetic retinopathy. Assessment of severity and progression. Ophthalmology 91:10\u201317","journal-title":"Ophthalmology"},{"key":"318_CR29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1365-2796.2003.01192.x","volume":"254","author":"ST Knudsen","year":"2003","unstructured":"Knudsen ST, Bek T, Poulsen PL et al (2003) Effects of losartan on diabetic maculopathy in type 2 diabetic patients: a randomized, double-masked study. J Intern Med 254:147\u2013158","journal-title":"J Intern Med"},{"key":"318_CR30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF00154206","volume":"14","author":"EB Leite","year":"1990","unstructured":"Leite EB, Mota MC, Faria de Abreu JR, Cunha-Vaz JG (1990) Effect of calcium dobesilate on the blood-retinal barrier in early diabetic retinopathy. Int Ophthalmol 14:81\u201388","journal-title":"Int Ophthalmol"},{"key":"318_CR31","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/archopht.119.10.1469","volume":"119","author":"CL Lobo","year":"2001","unstructured":"Lobo CL, Bernardes RC, de Abreu JR, Cunha-Vaz JG (2001) One-year follow-up of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes and mild nonproliferative retinopathy. Arch Ophthalmol 119:1469\u20131474","journal-title":"Arch Ophthalmol"},{"key":"318_CR32","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1001\/archopht.122.2.211","volume":"122","author":"CL Lobo","year":"2004","unstructured":"Lobo CL, Bernardes RC, Figueira JP et al (2004) Three-year follow-up of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy. Arch Ophthalmol 122:211\u2013217","journal-title":"Arch Ophthalmol"},{"key":"318_CR33","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2337\/diacare.20.4.621","volume":"20","author":"T Nakagami","year":"1997","unstructured":"Nakagami T, Kawahara R, Hori S, Omori Y (1997) Glycemic control and prevention of retinopathy in Japanese NIDDM patients. A 10-year follow-up study. Diabetes Care 20:621\u2013622","journal-title":"Diabetes Care"},{"key":"318_CR34","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1001\/jama.290.14.1884","volume":"290","author":"KM Narayan","year":"2003","unstructured":"Narayan KM, Boyle JP, Thompson TJ et al (2003) Lifetime risk for diabetes mellitus in the United States. JAMA 290:1884\u20131890","journal-title":"JAMA"},{"key":"318_CR35","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/BF00271264","volume":"32","author":"HH Parving","year":"1989","unstructured":"Parving HH, Larsen M, Hommel E, Lund-Andersen H (1989) Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive type 1 (insulin-dependent) diabetic patients with background retinopathy. Diabetologia 32:440\u2013444","journal-title":"Diabetologia"},{"key":"318_CR36","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/eye.1998.243","volume":"12","author":"AR Pearson","year":"1998","unstructured":"Pearson AR, Keightley SJ, Casswell AG (1998) How good are we at assessing driving visual fields in diabetics? Eye 12:938\u2013942","journal-title":"Eye"},{"key":"318_CR37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0168-8510(02)00143-4","volume":"64","author":"BC Polak","year":"2003","unstructured":"Polak BC, Crijns H, Casparie AF, Niessen LW (2003) Cost-effectiveness of glycemic control and ophthalmological care in diabetic retinopathy. Health Policy 64:89\u201397","journal-title":"Health Policy"},{"key":"318_CR38","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1056-8727(02)00188-5","volume":"16","author":"R Pradhan","year":"2002","unstructured":"Pradhan R, Fong D, March C, Jack R et al (2002) Angiotensin-converting enzyme inhibition for the treatment of moderate to severe diabetic retinopathy in normotensive type 2 diabetic patients. A pilot study. J Diabetes Complications 16:377\u2013381","journal-title":"J Diabetes Complications"},{"key":"318_CR39","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1055\/s-2008-1066758","volume":"114","author":"KP Ratzmann","year":"1989","unstructured":"Ratzmann KP, Raskovic M, Thoelke H (1989) Significance of proteinuria and hypertension in the prognosis of type 1 diabetes. Results of a 10-year follow-up study on micro- and macrovascular disease mortality[Article in German]. Dtsch Med Wochenschr 114:1311\u20131315","journal-title":"Dtsch Med Wochenschr"},{"key":"318_CR40","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ejphar.2004.05.019","volume":"495","author":"I Rota","year":"2004","unstructured":"Rota I, Chiavaroli C, Garay RP et al (2004) Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats. Eur J Pharmacol 495:217\u2013224","journal-title":"Eur J Pharmacol"},{"key":"318_CR41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2337\/diacare.8.1.57","volume":"8","author":"PW Russell","year":"1985","unstructured":"Russell PW, Sekuler R, Fetkenhour C (1985) Visual function after pan-retinal photocoagulation: a survey. Diabetes Care 8:57\u201363","journal-title":"Diabetes Care"},{"key":"318_CR42","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000308575","volume":"174","author":"I Salama-Benarroch","year":"1977","unstructured":"Salama-Benarroch I, Nano H, Perez H et al (1977) Assessment of calcium dobesilate in diabetic retinopathy. A double-blind clinical investigation. Ophthalmologica 174:47\u201351","journal-title":"Ophthalmologica"},{"key":"318_CR43","first-page":"214","volume":"52","author":"SL Saum","year":"2002","unstructured":"Saum SL, Thomas E, Lewis AM, Croft PR (2002) The effect of diabetic control on the incidence of, and changes in, retinopathy in type 2 non-insulin dependent diabetic patients. Br J Gen Pract 52:214\u2013216","journal-title":"Br J Gen Pract"},{"key":"318_CR44","first-page":"493","volume":"39","author":"M Schmidt","year":"1989","unstructured":"Schmidt M, Michal M (1989) Inhibition of sorbitol formation in human erythrocytes by calcium dobesilate. Arzneimittleforschung\/Drug Res 39:493\u2013495","journal-title":"Arzneimittleforschung\/Drug Res"},{"issue":"Suppl 3","key":"318_CR45","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1038\/sj.jhh.1001438","volume":"16","author":"AK Sjolie","year":"2002","unstructured":"Sjolie AK, Chaturvedi N (2002) The retinal renin-angiotensin system: implications for therapy in diabetic retinopathy. J Hum Hypertens 16 (Suppl 3):S42\u2013S46","journal-title":"J Hum Hypertens"},{"issue":"Suppl 3","key":"318_CR46","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1038\/sj.ijo.0801421","volume":"24","author":"FJ Snoek","year":"2000","unstructured":"Snoek FJ (2000) Barriers to good glycaemic control: the patient\u2019s perspective. Int J Obes Relat Metab Disord 24(Suppl 3):S12\u2013S20","journal-title":"Int J Obes Relat Metab Disord"},{"key":"318_CR47","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(03)14116-5","volume":"362","author":"H Stovring","year":"2003","unstructured":"Stovring H, Andersen M, Beck-Nielsen H et al (2003) Rising prevalence of diabetes: evidence from a Danish pharmaco-epidemiological database. Lancet 362:537\u2013538","journal-title":"Lancet"},{"key":"318_CR48","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0014-2999(01)01196-7","volume":"428","author":"ME Szabo","year":"2001","unstructured":"Szabo ME, Haines D, Garay E et al (2001) Antioxydant properties of calcium dobesilate in ischemic\/reperfused diabetic rat retina. Eur J Pharmacol 428:277\u2013286","journal-title":"Eur J Pharmacol"},{"key":"318_CR49","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1023\/A:1025369623365","volume":"18","author":"LJ Ubink-Veltmaat","year":"2003","unstructured":"Ubink-Veltmaat LJ, Bilo HJ, Groenier KH et al (2003) Prevalence, incidence and mortality of type 2 diabetes mellitus revisited: a prospective population-based study in the Netherlands (ZODIAC-1). Eur J Epidemiol 18:793\u2013800","journal-title":"Eur J Epidemiol"},{"key":"318_CR50","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1023\/A:1006132908679","volume":"22","author":"HJ Schaik Van","year":"1998\u201399","unstructured":"Van Schaik HJ, Benitez del Castillo JM, Caubergh MJ et al (1998\u201399) Evaluation of diabetic retinopathy by fluorophotometry. European concerted action on ocular fluorometry. Int Ophthalmol 22:97\u2013104","journal-title":"Int Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-006-0318-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-006-0318-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-006-0318-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T17:21:41Z","timestamp":1683480101000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-006-0318-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6,9]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,11,24]]}},"alternative-id":["318"],"URL":"https:\/\/doi.org\/10.1007\/s00417-006-0318-2","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6,9]]}}}